Florida doctors face new rules for medical marijuana (And how Arfinn Med can help)
TALLAHASSEE, Fla. – New rules laying out the do’s and don’ts physicians must follow when certifying patients to smoke medical marijuana took effect last week, but it’s not clear that doctors or patients are fully aware of them.
Patients certified or recertified to smoke medical marijuana must sign a new standardized consent form as of last Tuesday. That form for the first time includes information about the dangers of smoking near oxygen tanks and advises patients to check their marijuana supplies for mold contaminants.
Also, physicians must adhere to newly adopted practice standards that for the first time spell out what the doctors must do to certify patients and what information needs to be included in patients’ medical records.
Stories you may be interested in
The Lack of Clinical Trials in the Medical Marijuana Industry
As time goes on, medical marijuana is starting to break barriers in various states across the country. Out of the 50 states, 33 have approved a comprehensive medical marijuana program (NCSL). Currently, marijuana, medical or recreational, is illegal at the federal level, despite legalization in various states. Many medical professionals are interested in prescribing medical…
Read More 
Customize Your Patient Notes with Arfinn Med
Joining the text messaging update, the Arfinn Med portal now presents the ability to create note taking templates. This innovative addition will allow physicians to streamline the data and information that they are collecting from patients, resulting in their cases staying aligned and concise. Additionally, through this function, physicians will be able to pick and…
Read More 
After marijuana edibles helped dying Holocaust survivor battle Alzheimer’s, his family’s foundation pushes for more research
A Massachusetts family’s experience giving marijuana edibles to their dying patriarch is set to kick off a desperately needed investigation into how cannabis might treat some of the more troubling symptoms of Alzheimer’s disease, a condition that affects 5.7 million Americans. Read the full story here.
Read More 
Arfinn Med Patient Site
We get a lot of interest from patients asking about efficacy data for medical marijuana on a number of conditions. Though we are primarily an electronic medical record (EMR) company focussing on the cannabis industry and other complimentary or alternative therapies, our primary focus is better quality care for patients. So with that being said,…
Read More 
Arfinn Med March Updates
We are very happy to announce the release of several new functions within the Arfinn Med Platform. Those include: * Text message updates from patients regarding their treatments * Templating for exam notes * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More 
Norfolk research company plans clinical trials using medical marijuana
Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More